EUVIMEDSkopri EUVIMED
Crossref

Serum Thrombospondin-1 Levels by Glycemic Status in Type 2 Diabetes — a Pilot Study

Dwi Suci Irianti, Liong Boy Kurniawan, Nurahmi Nurahmi, Andi Alfian Zainuddin, Himawan Dharmayani

Clinical Diabetology · 2026-11-16

DOI: 10.5603/cd.115165 ↗

At a glance

Journal article in Clinical Diabetology, published online on 2026-11-16. Written by Dwi Suci Irianti and 4 co-authors.

AstrattDettalji biblijografiċiCiteRelated studies

Abstract (original language)

Background

Thrombospondin-1 (TSP-1) is a matricellular glycoprotein involved in angiogenesis, vascular homeostasis, and metabolic signaling. Elevated circulating TSP-1 levels have been associated with diabetes and glycemic parameters, but evidence regarding differences according to glycemic-control status remains limited. This study aimed to compare serum TSP-1 levels between controlled and uncontrolled type 2 diabetes (T2D) and to explore their associations with glycemic and clinical variables.

Methods

A cross-sectional study was conducted among 85 adults with T2D recruited from Hasanuddin University Hospital and Dr. Wahidin Sudirohusodo General Hospital, Makassar, Indonesia. Glycemic control was classified as controlled (HbA1c < 7%) or uncontrolled (HbA1c ≥7%). Serum TSP-1 levels were measured using enzyme-linked immunosorbent assay (ELISA). Group differences were analyzed using the Mann–Whitney U test, while associations between TSP-1 and clinical variables were examined using Spearman’s rank correlation.

Results

Of the 85 participants, 16 (18.8%) had controlled glycemic status and 69 (81.2%) had uncontrolled glycemic status. Median serum TSP-1 levels were 42.72 ng/mL (IQR 35.29) in the controlled group and 43.95 ng/mL (IQR 35.38) in the uncontrolled group, with no significant difference between groups (U = 438.0, p = 0.200). Serum TSP-1 levels showed weak positive correlations with HbA1c (ρ = 0.216, p = 0.047) and fasting plasma glucose (ρ = 0.265, p = 0.015), and a weak negative correlation with age (ρ = −0.267, p = 0.014). No significant correlations were found with body mass index, lipid profile, platelet count, or blood pressure.

Conclusions

Serum TSP-1 levels did not differ significantly according to HbA1c-defined glycemic-control status in patients with T2D. However, weak positive associations with HbA1c and fasting plasma glucose suggest a potential relationship between TSP-1 and glycemic regulation. Larger studies with balanced group sizes and multivariable analyses are warranted to clarify the clinical significance of TSP-1 in T2D.

Cite

APA

Irianti, D. S., Kurniawan, L. B., Nurahmi, N., Zainuddin, A. A., & Dharmayani, H. (2026). Serum Thrombospondin-1 Levels by Glycemic Status in Type 2 Diabetes — a Pilot Study. Clinical Diabetology. https://doi.org/10.5603/cd.115165

Vancouver

Irianti DS, Kurniawan LB, Nurahmi N, Zainuddin AA, Dharmayani H. Serum Thrombospondin-1 Levels by Glycemic Status in Type 2 Diabetes — a Pilot Study. Clinical Diabetology. 2026. doi:10.5603/cd.115165

BibTeX
@article{Irianti2026,
  author = {Irianti, Dwi Suci and Kurniawan, Liong Boy and Nurahmi, Nurahmi and Zainuddin, Andi Alfian and Dharmayani, Himawan},
  title = {Serum Thrombospondin-1 Levels by Glycemic Status in Type 2 Diabetes — a Pilot Study},
  journal = {Clinical Diabetology},
  year = {2026},
  doi = {10.5603/cd.115165}
}
Start for free →